HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes

Journal of General Virology

Volumn 91, Issue 1, 2010, Pages 235-241

  Baroni, Miriam ^a,b   Matucci, Andrea ^c   Scarlatti, Gabriella ^b   Soprana, Elisa ^b   Rossolillo, Paola ^c   Lopalco, Lucia ^b   Zipeto, Donato ^c   Siccardi, Antonio G ^a,b   De Santis, Claudio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; SMALL INTERFERING RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RNA INTERFERENCE; TARGET CELL; VIRUS ENTRY; VIRUS ISOLATION; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; GENE SILENCING; HIV-1; HLA-C ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; RNA, SMALL INTERFERING; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 73149089063     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.015230-0     Document Type: Article

References (28)

1. Arosa, F. A., Santos, S. G. & Powis, S. J. (2007). Open conformers: the hidden face of MHC-I molecules. Trends Immunol 28, 115-123.
2. b by the NK cell inhibitory receptor Ly49C. J Immunol 175, 3542-3553.
3. Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K. & O'Brien, S. J. (1999). HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752.
4. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L. & Baltimore, D. (1999). The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671.
5. Connor, R. I., Chen, B. K., Choe, S. & Landau, N. R. (1995). Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935-944.
6. Cosma, A., Blanc, D., Braun, J., Quillent, C., Barassi, C., Moog, C., Klasen, S., Spire, B., Scarlatti, G. & other authors (1999). Enhanced HIV infectivity and changes in gp120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. AIDS 13, 2033-2042.
7. De Santis, C., Robbioni, P., Longhi, R., Carrow, E., Siccardi, A. G. & Beretta, A. (1996). Role of HLA class I in HIV type 1-induced syncytium formation. AIDS Res Hum Retroviruses 12, 1031-1040.
8. Eckert, D. M. & Kim, P. S. (2001). Design of potent inhibitors of HIV- 1 entry from the gp41 N-peptide region. Proc Natl Acad Sci U S A 98, 11187-11192.
9. Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A. & other authors (2007). A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944-947.
10. Gonen-Gross, T., Achdout, H., Arnon, T. I., Gazit, R., Stern, N., Horejsi, V., Goldman-Wohl, D., Yagel, S. & Mandelboim, O. (2005). The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules. J Immunol 175, 4866-4874.
11. Grassi, F., Meneveri, R., Gullberg, M., Lopalco, L., Rossi, G. B., Lanza, P., De Santis, C., Brattsand, G., Butto, S. & other authors (1991). Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J Exp Med 174, 53-62.
12. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O. & Landau, N. R. (1995). Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 69, 6705-6711.
13. Joliot, V., Goujon, C., Dumonceaux, J., Renard, A., Briand, P. & Hazan, U. (2001). A human immunodeficiency virus Env inducible transcription system to examine consequences of gp120 expression. J Virol Methods 98, 145-151.
14. Kirchherr, J. L., Lu, X., Kasongo, W., Chalwe, V., Mwananyanda, L., Musonda, R. M., Xia, S. M., Scearce, R. M., Liao, H. X. & other authors (2007). High throughput functional analysis of HIV-1 env genes without cloning. J Virol Methods 143, 104-111.
15. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P. & other authors (2005). Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79, 10108-10125.
16. Limou, S., Le Clerc, S., Coulonges, C., Carpentier, W., Dina, C., Delaneau, O., Labib, T., Taing, L., Sladek, R. & other authors (2009). Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199, 419-426.
17. Mascola, J. R., Louder, M. K., Winter, C., Prabhakara, R., De Rosa, S. C., Douek, D. C., Hill, B. J., Gabuzda, D. & Roederer, M. (2002). Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J Virol 76, 4810-4821.
18. Matucci, A., Rossolillo, P., Baroni, M., Siccardi, A. G., Beretta, A. & Zipeto, D. (2008). HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 5, 68.
19. Mitra, A. K., Celia, H., Ren, G., Luz, J. G., Wilson, I. A. & Teyton, L. (2004). Supine orientation of a murine MHC class I molecule on the membrane bilayer. Curr Biol 14, 718-724.
20. Natali, P. G., Nicotra, M. R., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P. & Russo, C. (1989). Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc Natl Acad Sci U S A 86, 6719-6723.
21. Rousseau, C. M., Birditt, B. A., McKay, A. R., Stoddard, J. N., Lee, T. C., McLaughlin, S., Moore, S. W., Shindo, N., Learn, G. H. & other authors (2006). Large-scale amplification, cloning and sequencing of near fulllength HIV-1 subtype C genomes. J Virol Methods 136, 118-125.
22. Rusconi, S., Scozzafava, A., Mastrolorenzo, A. & Supuran, C. T. (2007). An update in the development of HIV entry inhibitors. Curr Top Med Chem 7, 1273-1289.
23. Schwartz, O., Alizon, M., Heard, J. M. & Danos, O. (1994). Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology 198, 360-365.
24. 2-microglobulin. Hum Immunol 46, 69-81.
25. Shimizu, Y., Geraghty, D. E., Koller, B. H., Orr, H. T. & DeMars, R. (1988). Transfer and expression of three cloned human non-HLA-A, B, C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A 85, 227-231.
26. van Manen, D., Kootstra, N. A., Boeser-Nunnink, B., Handulle, M. A., van't Wout, A. B. & Schuitemaker, H. (2009). Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23, 19-28.
27. Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M. & Kappes, J. C. (2002). Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46, 1896-1905.
28. White, J., Matlin, K. & Helenius, A. (1981). Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol 89, 674-679.